04th week of 2021 patent applcation highlights part 27 |
Patent application number | Title | Published |
20210024889 | ANTIBODY GENE EDITING IN B LYMPHOCYTES | 2021-01-28 |
20210024890 | MODULATING T CELL FUNCTION AND RESPONSE | 2021-01-28 |
20210024891 | METHODS AND COMPOSITIONS FOR INDUCING HEMATOPOIETIC CELL DIFFERENTIATION | 2021-01-28 |
20210024892 | Precursor Cells Of Induced Pluripotent Stem Cell (IPSC)-Derived Mesenchymal Stem Cells And Method For Preparing The Same | 2021-01-28 |
20210024893 | MEDICAL USES OF EXOSOMES | 2021-01-28 |
20210024894 | BIOLOGIC COMPOSITION AND METHOD OF MANUFACTURE | 2021-01-28 |
20210024895 | RNA PREPARATIONS COMPRISING PURIFIED MODIFIED RNA FOR REPROGRAMMING CELLS | 2021-01-28 |
20210024896 | METHOD FOR PRODUCING STEM CELL-DERIVED LACRIMAL GLAND TISSUE | 2021-01-28 |
20210024897 | PLURIPOTENT STEM CELL DIFFERENTIATION-PROMOTING AGENT | 2021-01-28 |
20210024898 | OPTICAL-QUALITY SURFACE THAT IMPARTS SPATIAL CONTROL OF MACROPHAGE FUSION | 2021-01-28 |
20210024899 | VIRULENT PSEUDOMONAS FLUORESCENS PHAGE Pf1901, AND PHAGE Pf1901 PREPARATION AND APPLICATION THEREOF | 2021-01-28 |
20210024900 | METHODS AND COMPOSITIONS RELATED TO INCREASED ROTAVIRUS PRODUCTION | 2021-01-28 |
20210024901 | METHOD FOR CHANGING COENZYME ACTIVITY AND PREFERENCE OF GLUCOSE DEHYDROGENASE AND USE THEREOF | 2021-01-28 |
20210024902 | L-GLUTAMATE DEHYDROGENASE MUTANT AND APPLICATION THEREOF | 2021-01-28 |
20210024903 | COMPOSITIONS AND METHODS RELATING TO A MUTANT CLOSTRIDIUM DIFFICILE TOXIN | 2021-01-28 |
20210024904 | TRANSAMINASE MUTANT AND USE THEREOF | 2021-01-28 |
20210024905 | NOVEL HYDROLASE AND METHOD FOR PRODUCING (1S,2S)-1-ALKOXYCARBONYL-2-VINYLCYCLOPROPANE CARBOXYLIC ACID USING SAME | 2021-01-28 |
20210024906 | COMPLEX FOR GENOME EDITING HAVING STABILITY AND FEW SIDE-EFFECTS, AND NUCLEIC ACID CODING SAME | 2021-01-28 |
20210024907 | NUCLEIC ACID-BASED THERAPEUTICS | 2021-01-28 |
20210024908 | AMYLASE MUTANT HAVING HIGH SPECIFIC ACTIVITY AND THERMAL STABILITY, GENE OF MUTANT, AND APPLICATIONS THEREOF | 2021-01-28 |
20210024909 | CHIMERIC AMYLASES COMPRISING AN HETEROLOGOUS STARCH BINDING DOMAIN | 2021-01-28 |
20210024910 | Mannanase Variants and Polynucleotides Encoding Same | 2021-01-28 |
20210024911 | NUCLEOSIDASE AGENT HAVING REDUCED CONTAMINANT ACTIVITY | 2021-01-28 |
20210024912 | Cell-Free Expression System Having Novel Inorganic Polyphosphate-Based Energy Regeneration | 2021-01-28 |
20210024913 | ANIMAL PRODUCT FREE SYSTEM AND PROCESS FOR PURIFYING A BOTULINUM TOXIN | 2021-01-28 |
20210024914 | NUCLEIC ACID ENCODING AN ISOMERASE AND USES THEREOF | 2021-01-28 |
20210024915 | METHOD FOR ACTIVATING P21 GENE EXPRESSION | 2021-01-28 |
20210024916 | USING NUCLEOSOME INTERACTING PROTEIN DOMAINS TO ENHANCE TARGETED GENOME MODIFICATION | 2021-01-28 |
20210024917 | Methods for Enhancing Bacterial Cell Display of Proteins and Peptides | 2021-01-28 |
20210024918 | MICROBIAL STRAIN IMPROVEMENT BY A HTP GENOMIC ENGINEERING PLATFORM | 2021-01-28 |
20210024919 | FUNCTIONALIZED SOLID SUPPORT | 2021-01-28 |
20210024920 | Integrative DNA and RNA Library Preparations and Uses Thereof | 2021-01-28 |
20210024921 | Methods and Compositions for Generating a Deletion Library and for Identifying a Defective Interfering Particle (DIP) | 2021-01-28 |
20210024922 | THERAPEUTIC METHOD FOR HUNTINGTON'S DISEASE | 2021-01-28 |
20210024923 | COMPOSITIONS AND METHODS FOR MODULATING TTR EXPRESSION | 2021-01-28 |
20210024924 | NUCLEASE SYSTEMS FOR GENETIC ENGINEERING | 2021-01-28 |
20210024925 | OLIGONUCLEOTIDES FOR MODULATING ATXN2 EXPRESSION | 2021-01-28 |
20210024926 | FULLY STABILIZED ASYMMETRIC SIRNA | 2021-01-28 |
20210024927 | CHIMERIC PROMOTER WITH HIGH TRANSCRIPTIONAL ACTIVITY IN T-CELLS | 2021-01-28 |
20210024928 | C/EBP ALPHA SARNA COMPOSITIONS AND METHODS OF USE | 2021-01-28 |
20210024929 | NUCLEIC ACID COMPLEX | 2021-01-28 |
20210024930 | METHOD OF PRODUCING HAIRPIN SINGLE-STRANDED RNA MOLECULE | 2021-01-28 |
20210024931 | METHOD FOR INDUCING RNA SILENCING | 2021-01-28 |
20210024932 | SPLICE-SWITCHING OLIGONUCLEOTIDES AND METHODS OF USE | 2021-01-28 |
20210024933 | Splint nucleic acid molecule for cyclizing single-stranded nucleic acid molecule and use thereof | 2021-01-28 |
20210024934 | USE OF FUBP1 INHIBITORS FOR TREATING HEPATITIS B VIRUS INFECTION | 2021-01-28 |
20210024935 | Read Through Of Truncated Proteins In Premature Termination Codon Diseases Using An Optimized Genetic Codon Expansion System | 2021-01-28 |
20210024936 | THERAPEUTIC TARGETING OF ONCOGENES USING EXOSOMES | 2021-01-28 |
20210024937 | Methods of Modulating Lymphangiogenesis, E.g., to Treat Corneal Transplant Rejection, in a Subject | 2021-01-28 |
20210024938 | SOLUBLE INTERLEUKIN-7 RECEPTOR (SIL7R) MODULATING THERAPY TO TREAT AUTOIMMUNE DISEASES AND CANCER | 2021-01-28 |
20210024939 | DEVELOPMENT OF TECHNOLOGY FOR INDUCING OVER-EXPRESSION OF β-AGARASE DAGA ENZYME | 2021-01-28 |
20210024940 | RECOMBINANT THERAPEUTIC INTERVENTIONS FOR CANCER | 2021-01-28 |
20210024941 | METHOD FOR SECRETORY PRODUCTION OF PROTEIN | 2021-01-28 |
20210024942 | AUREOBASIDIUM PULLULANS STRAINS WITH HIGH-YIELD HEAVY OIL AND CONSTRUCTION METHOD AND APPLICATION THEREOF | 2021-01-28 |
20210024943 | COMPOSITIONS AND METHODS FOR MODIFYING GENOMES | 2021-01-28 |
20210024944 | METHOD OF PRODUCING ALKALOID | 2021-01-28 |
20210024945 | THE FATTY ACID DESATURASE 2 FAMILY IN TOMATO | 2021-01-28 |
20210024946 | ISOLATED POLYPEPTIDES AND POLYNUCLEOTIDES USEFUL FOR INCREASING NITROGEN USE EFFICIENCY, ABIOTIC STRESS TOLERANCE, YIELD AND BIOMASS IN PLANTS | 2021-01-28 |
20210024947 | SHATTERPROOF GENES AND MUTATIONS | 2021-01-28 |
20210024948 | ENHANCEMENT OF PHOTOSYNTHETIC RATES, ABIOTIC STRESS TOLERANCE AND BIOMASS YIELD THROUGH EXPRESSIOPN OF A C4 PLANT FERREDOXIN IN C3 PHOTOSYNTHETIC PLANTS | 2021-01-28 |
20210024950 | NOVEL GENETIC LOCI ASSOCIATED WITH DISEASE RESISTANCE IN SOYBEANS | 2021-01-28 |
20210024951 | QTLS FOR POWDERY MILDEW RESISTANCE IN MELON | 2021-01-28 |
20210024952 | EXPRESSION VECTOR ELEMENT COMBINATIONS, NOVEL PRODUCTION CELL GENERATION METHODS AND THEIR USE FOR THE RECOMBINANT PRODUCTION OF POLYPEPTIDES | 2021-01-28 |
20210024953 | METHODS AND COMPOSITIONS FOR TARGETED GENETIC MODIFICATIONS AND METHODS OF USE | 2021-01-28 |
20210024954 | RECOMBINANT VERSICAN ISOFORMS AND RELATED COMPOSITIONS AND METHODS | 2021-01-28 |
20210024955 | METHODS AND COMPOSITIONS FOR INDUCIBLE EXPRESSION OF NEUROTROPHIC FACTORS | 2021-01-28 |
20210024956 | GENE THERAPY STRATEGY TO RESTORE CARDIAC ELECTRICAL AND STRUCTURAL FUNCTION IN ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY | 2021-01-28 |
20210024957 | ENGINEERED TARGET SPECIFIC NUCLEASES | 2021-01-28 |
20210024958 | ENGINEERED TARGET SPECIFIC NUCLEASES | 2021-01-28 |
20210024959 | ENGINEERED IMMUNE EFFECTOR CELLS AND USE THEREOF | 2021-01-28 |
20210024960 | ENGINEERED MICROBES FOR CONVERSION OF ORGANIC COMPOUNDS TO MEDIUM CHAIN LENGTH ALCOHOLS AND METHODS OF USE | 2021-01-28 |
20210024961 | SECONDARY ACETATE FERMENTATION | 2021-01-28 |
20210024962 | SUPPLEMENTED MIXOTROPHIC FERMENTATION METHOD | 2021-01-28 |
20210024963 | METHOD FOR PRODUCING ORGANIC SUBSTANCE | 2021-01-28 |
20210024964 | YEAST STAGE TANK INCORPORATED FERMENTATION SYSTEM AND METHOD | 2021-01-28 |
20210024965 | ENGINEERED MICROBES FOR CONVERSION OF ORGANIC COMPOUNDS TO BUTANOL AND METHODS OF USE | 2021-01-28 |
20210024966 | METHOD OF OBTAINING A MICROBIAL OIL AND A METHOD OF REDUCING EMULSION BY MAINTAINING A LOW CONCENTRATION OF CARBOHYDRATE | 2021-01-28 |
20210024967 | BIOTECHNOLOGICAL PRODUCTION OF ALCOHOLS AND DERIVATIVES THEREOF | 2021-01-28 |
20210024968 | GENETICALLY ENGINEERED MICROORGANISMS AND PROCESSES FOR THE PRODUCTION OF CANNABINOIDS FROM A CARBON SOURCE PRECURSOR | 2021-01-28 |
20210024969 | Mutant Beta-Glucosidase | 2021-01-28 |
20210024970 | METHOD FOR PRODUCING A DEUTERATED OR TRITIATED NAD(P)H | 2021-01-28 |
20210024971 | METHODS FOR PRODUCING, DISCOVERING, AND OPTIMIZING LASSO PEPTIDES | 2021-01-28 |
20210024972 | METHODS TO IMPROVE OXYGEN DELIVERY TO IMPLANTABLE SENSORS | 2021-01-28 |
20210024973 | METHOD FOR MICROBIAL SPECIES DETECTION, QUANTIFICATION AND ANTIBIOTIC SUSCEPTIBILITY IDENTIFICATION | 2021-01-28 |
20210024974 | High-Throughput Cell-Based Screening Methodology For Evaluating Carbohydrate-Active Enzymes | 2021-01-28 |
20210024975 | METHODS FOR IDENTIFYING INHIBITORS OF LIPID A DEACYLASE AND EXPRESSION VECTORS RELATED TO SAME | 2021-01-28 |
20210024976 | PROBE SET FOR ANALYZING A DNA SAMPLE AND METHOD FOR USING THE SAME | 2021-01-28 |
20210024977 | SINGLE CELL CHROMATIN IMMUNOPRECIPITATION SEQUENCING ASSAY | 2021-01-28 |
20210024978 | METHOD FOR INDICATING THE PROGRESS OF AMPLIFICATION OF NUCLEIC ACIDS AND KIT FOR PERFORMING THE SAME | 2021-01-28 |
20210024979 | LISTERIA-MONOCYTOGENES DETECTION METHOD | 2021-01-28 |
20210024980 | POLYNUCLEOTIDES FOR THE AMPLIFICATION AND DETECTION OF NEISSERIA GONORRHOEAE | 2021-01-28 |
20210024981 | COMPOSITION FOR DETECTING DSRNAS, COMPRISING MEROCYANINE COMPOUND AND ISOMER THEREOF, AND METHOD FOR PROVIDING INFORMATION FOR DIAGNOSING CANCER, BY USING DSRNA EXPRESSION ANALYSIS | 2021-01-28 |
20210024982 | INACTIVATABLE TARGET CAPTURE OLIGOMERS FOR USE IN THE SELECTIVE HYBRIDIZATION AND CAPTURE OF TARGET NUCLEIC ACID SEQUENCES | 2021-01-28 |
20210024983 | NUCLEIC ACID ANALYSIS METHOD AND APPARATUS | 2021-01-28 |
20210024984 | Method for Identifying One or More Mutations in a Hotspot Mutation Sequence | 2021-01-28 |
20210024985 | Devices and Methods Useful for Imaging Transient and Rare Mechanical Events in Cells | 2021-01-28 |
20210024986 | OLIGONUCLEOTIDES AND METHODS FOR INTERNAL CONTROL OF EUKARYOTIC DNA AMPLIFICATION REACTIONS | 2021-01-28 |
20210024987 | Nucleic Acid Amplification | 2021-01-28 |
20210024988 | NOVEL IMMUNOPROBE-BASED METHOD TO ASSESS ORGAN INJURY STATUS THROUGH A BIOFLUID-BASED CELL-FREE DNA (CFDNA) ASSAY | 2021-01-28 |
20210024989 | SYSTEMS AND METHODS FOR ALLELE ENRICHMENT USING MULTIPLEXED BLOCKER DISPLACEMENT AMPLIFICATION | 2021-01-28 |